Celldex Therapeutics Inc. (CLDX) Fell -7.14% or -0.05 To Price $0.6 On Wednesday


Celldex Therapeutics Inc. (CLDX) fell -7.14% or -0.05 to $0.6. It is near 2.92 million shares traded, which is 100.43% compare to the average total volume 2.90 million. The market cap of CLDX is $86.55 million. The year to date change is -791.54%. The 52 week price range is from $0.58 to $3.26. Price of CLDX have changed -0.79% during last week. It have changed -9.72% over last month, -76.95% over last 3 months, -77.89% over last 6 months and -71.86% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CLDX is 0.95. It is 58.33% above current price. The 200-day Moving Averages for CLDX is 2.26. It is 276.67% above current price. The 52-week High is 3.26. It is 443.33% from the current price. The 52-week Low is 0.58. It is -3.33% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CLDX is 3.07 on 2018-05-31. Short % to float is 6.28%. There are some statistics of CLDX. It is has market cap $86.55 million. The share outstanding is 143.39 million. The average volume is 2.90 million. The revenue is 7.75M. The percent of top 15 Institution holding is 45.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CLDX is -92.64%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CLDX is -64.16%.


Tags:

Share this post